Speak to a Lawyer Immediately - Free Consultation - 1-800-840-2111
Yaz Lawsuit Updates
Since 2004, thousands of patients taking birth Yasmin and Yaz birth control pills have come forward with complaints of blood clots, gallbladder problems, and kidney problems related to their prescriptions. Despite years of complaints to the Federal Drug Administration, the government agency has not recalled the product, made by manufacturer Bayer. That could change, as the FDA has announced more recently that it will consider a set of British studies which showed that blood clots were up to three times more common for women taking birth control pills containing drospirenone, an active ingredient in Yasmin and Yaz. The results are sure to impact California Yaz lawsuits.
With more than 4,000 women filing complaints against Yaz birth control manufacturer Bayer in a multi-district litigation, California Yaz lawsuits continue to move forward. Common among these complaints is the accusation that Bayer wrongly marketed its popular birth control drug toward teenagers promising that in addition to preventing pregnancies, Yaz would reduce acne and prevent a severe form of premenstrual syndrome. And while Bayer advertised some of the Yaz side effects, it never mentioned the potential for blood clots, gall bladder disease, and even strokes, symptoms that have been increasingly accepted by the medical community.
Last week, the Yaz MDL court sided with Bayor and ruled that third-party claims against the drug maker were too remote to justify sufficient injury necessary for standing. According to the brief, the plaintiffs argued that anyone who “purchased, reimbursed, and/or paid for all or part of the cost of YAZ” should be able to sue the drug’s parent company Bayer because it engaged in “fraudulent, misleading, and unlawful advertising campaign that wrongfully promoted YAZ as safe and effective for unapproved off-label uses and concelaed or omitted facts pertaining to YAZ’s safety profile.”
California Yaz Lawsuits Heat Up
23 Jun 2010Since the Judicial Panel on MultiDistrict Litigation (JPML) decided that Yaz cases could be consolidated in the Southern District of Illinois last October, the suits have really started to heat up. In May, the Plaintiffs Steering Committee met to assign leadership roles and begin communicating with defendants and make decisions on behalf of Yaz lawsuits here in California. On the federal level, Bayer has provided the MDL Discovery Committee millions of Yasmin and Yaz documents to review and code.
The hearing that took place on September 24th to determine whether or not Yaz cases should be combined into multidistrict litigation (MDL) has been decided. The Judicial Panel on MultiDistrict Litigation (JPML) approved MDL-2100, “In Re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation” on October 1st. What does this mean for [...]
The FDA sent out warning letters to several big pharmaceutical companies in March of this year warning them that their internet advetisements were misleading and did not disclose all the information that US regulations require them to. As a result, many companies pulled their ads completely, resulting in a 59% drop in sponsored link exposures, [...]
The side effects of Yaz and Yasmin can result in serious injury or death. Already we have received calls and emails from over 500 women who have suffered side effects ranging from stroke, to deep vein thrombosis, to heart attack. Sadly, we have even received calls from family members who have lost a loved one to [...]
The U.S. Judicial Panel on Multidistrict Litigation recently issued a notice (see page 22 of PDF) that a hearing will be held on September 24 to determine whether it’s appropriate to consolidate Yaz lawsuits from across the country. A motion was filed last month by lawyers on behalf of a number of Yaz consumers in California, [...]
California Attorney General Jerry Brown made public a settlement with Bayer last Friday in which the drug company agreed to pay $20 million to correct false advertising about Yaz. Bayer had advertised Yaz as a remedy for mild acne, without receiving approval. Brown commented: “Bayer’s deceptive ad campaign led young women to believe that its [...]
Why Contact Our Firm?
With over $150 Million recovered from major drug, medical device, and medical malpractice cases in the last five years alone, our attorneys are rated among the best in California by our peers.
We take cases on a contingency basis, meaning we are only paid if we win or settle your case, and consultations are ALWAYS free.
Learn More About Us »